Query author contributions in Reactome

Reactome depends on collaboration between our curation team and outside experts to assemble and peer-review its pathway modules. The integration of ORCID within Reactome enables us to meet a key challenge with authoring, curating and reviewing biological information by incentivizing and crediting the external experts that contribute their expertise and time to the Reactome curation process. More information is available at ORCID and Reactome.

If you have an ORCID ID that is not listed on this page, please forward this information to us and we will update your Reactome pathway records.

Details on Person Jassal, Bijay, 2017-08-08

Class:Id	InstanceEdit:9015102
_displayName	Jassal, Bijay, 2017-08-08
_timestamp	2017-08-08 13:04:26
author	[Person:73447] Jassal, Bijay
dateTime	2017-08-08 17:03:47
(created)	[Person:9015059] Patel, Manesh R [LiteratureReference:9015060] The new oral anticoagulants for the treatment of venous thromboembolism: a new paradigm shift in antithrombotic therapy [Person:9015061] Galanis, Taki [LiteratureReference:9015062] Dabigatran, Rivaroxaban, or Apixaban versus Warfarin in Patients with Nonvalvular Atrial Fibrillation: A Systematic Review and Meta-Analysis of Subgroups [Person:9015063] Lampe, Thomas [LiteratureReference:9015064] Rivaroxaban: a novel, oral, direct factor Xa inhibitor [LiteratureReference:9015065] Discovery of the novel antithrombotic agent 5-chloro-N-({(5S)-2-oxo-3- [4-(3-oxomorpholin-4-yl)phenyl]-1,3-oxazolidin-5-yl}methyl)thiophene- 2-carboxamide (BAY 59-7939): an oral, direct factor Xa inhibitor [Person:9015066] Abrams, Paris J [Person:9015067] Siegal, Deborah M [LiteratureReference:9015068] The discovery and development of rivaroxaban List all 45 refering instances
(modified)	[Summation:140679] Factor Xa (FXa), a cleavage product of coagulation factor X ... [Summation:140701] Factor Xa catalyzes the activation of small amounts of throm... [PathwayDiagram:480992] Diagram of OBSOLETE_Formation of Fibrin Clot (Clotting Cascade)_REPLACEMENT_9769740
[Change default viewing format]

No pathways have been reviewed or authored by Jassal, Bijay, 2017-08-08 (9015102)